Inventor
DECKERT JUTTA
US14 patents
⚠️ This page may combine multiple inventors who share the name “DECKERT JUTTA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DEBIOPHARM INT SA
7 patentsUS11466095B2Oct 11, 2022
CD37-binding molecules and immunoconjugates thereof
DEBIOPHARM INT SA3 citations83
US10556958B2Feb 11, 2020
CD37-binding molecules and immunoconjugates thereof
DEBIOPHARM INT SA7 citations83
US10202460B2Feb 12, 2019
CD37-binding molecules and immunoconjugates thereof
DEBIOPHARM INT SA7 citations83
US11395796B2Jul 26, 2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations
DEBIOPHARM INT SA5 citations79
US11104740B2Aug 31, 2021
Antibodies and assays for detection of CD37
DEBIOPHARM INT SA2 citations67
US12559566B2Feb 24, 2026
CD37-binding molecules immunoconjugates thereof
DEBIOPHARM INT SA0 citations62
US12239732B2Mar 4, 2025
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations
DEBIOPHARM INT SA0 citations57
DECKERT JUTTA
5 patentsUS8765917B2Jul 1, 2014
CD37-binding molecules and immunoconjugates thereof
DECKERT JUTTA31 citations95
US9173961B2Nov 3, 2015
CD20 antibodies and uses thereof
DECKERT JUTTA8 citations83
US9447189B2Sep 20, 2016
CD37-binding molecules and immunoconjugates thereof
DECKERT JUTTA13 citations82
US9314522B2Apr 19, 2016
Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
DECKERT JUTTA3 citations66
US9175086B2Nov 3, 2015
CD20 antibodies and uses thereof
DECKERT JUTTA0 citations50